Direct effects of selective type 5 phosphodiesterase inhibitors alone or with other vasodilators on the erectile response in cats.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Urology

• Publication date

  2001-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0022-5347(05)66592-5PMID 11176530
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle

  2005cited by this paper
• Signal transduction in cavernous smooth muscle

  2005cited by this paper
• Penile erections induced by vasoactive intestinal peptide and sodium nitroprusside

  2004cited by this paper
• Oral sildenafil in the treatment of erectile dysfunction. 1998.

  2002cited by this paper
• Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney.

  1999cited by this paper
• Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro.

  1999cited by this paper
• Induction of penile erection by intracavernosal and transurethral administration of novel nitric oxide donors in the cat.

  1999cited by this paper
• Effects of castration and androgen replacement on erectile function in a rabbit model.

  1999cited by this paper
• Overall cardiovascular profile of sildenafil citrate.

  1999cited by this paper
• Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4).

  1999cited by this paper
• Sildenafil Citrate, a Selective Phosphodiesterase Type 5 Inhibitor:

  1999cited by this paper
• Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.

  1998cited by this paper
• The effect of the specific phosphodiesterase (PDE) inhibitors on human and rabbit cavernous tissue in vitro and in vivo.

  1998cited by this paper
• Sildenafil, a type-5 CGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro.

  1998cited by this paper
• Effect of the selective phosphodiesterase type 5 inhibitor sildenafil on erectile dysfunction in the anesthetized dog.

  1998cited by this paper
• Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes.

  1998cited by this paper
• Identification and Characterization of a Novel Family of Cyclic Nucleotide Phosphodiesterases*

  1998cited by this paper
• Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction.

  1998cited by this paper
• The influence of castration on pharmacologically induced penile erection in the cat.

  1998cited by this paper
• Androgenic maintenance of the rat erectile response via a non-nitric-oxide-dependent pathway.

  1997cited by this paper
• Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro.

  1997cited by this paper
• G-protein-coupled receptor agonists augment adenylyl cyclase activity induced by forskolin in human corpus cavernosum smooth muscle cells.

  1997cited by this paper
• Oral, Transdermal, and Transurethral Therapies for Erectile Dysfunction

  1997cited by this paper
• Male Infertility and Sexual Dysfunction

  1997cited by this paper
• Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.

  1996cited by this paper
• MINIREVIEW Role of Nitric Oxide in the Physiology of Erection

  1995cited by this paper
• Preliminary results of a comparative study with intracavernous sodium nitroprusside and prostaglandin E1 in patients with erectile dysfunction.

  1995cited by this paper
• Role of nitric oxide in the physiology of erection.

  1995cited by this paper
• Nitric oxide mediates penile erection in cats.

  1994cited by this paper
• Smooth muscle tone regulation in rabbit cavernosal and spongiosal tissue by cyclic AMP- and cyclic GMP-dependent mechanisms.

  1994cited by this paper
• Rat model for the study of penile erection: pharmacologic and electrical-stimulation parameters.

  1994cited by this paper
• Adenylate and guanylate cyclase activity in the penis and aorta of the diabetic rat: an in vitro study.

  1994cited by this paper
• Multiple cyclic nucleotide phosphodiesterases.

  1994cited by this paper
• Intracellular mechanism of penile erection in monkeys

  1994cited by this paper
• The role of cyclic adenosine monophosphate, cyclic guanosine monophosphate, endothelium and nonadrenergic, noncholinergic neurotransmission in canine penile erection.

  1993cited by this paper
• Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis.

  1993cited by this paper
• Cyclic guanosine monophosphate mediates penile erection in the rat.

  1993cited by this paper
• Intracavernous sodium nitroprusside: inappropriate impotence treatment.

  1993cited by this paper
• Nitric oxide mediates neurogenic relaxation induced in rabbit cavernous smooth muscle by electric field stimulation.

  1992cited by this paper
• Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission.

  1992cited by this paper
• Nitric oxide: a physiologic mediator of penile erection.

  1992cited by this paper
• A possible neural source of nitric oxide in the rat penis.

  1992cited by this paper
• Potassium channel agonists cause penile erection in cats.

  1992cited by this paper
• Characterization of inhibitory neurotransmission in the isolated corpus cavernosum from rabbit and man.

  1992cited by this paper
• Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission

  1992cited by this paper
• A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle.

  1991cited by this paper
• Effects of the nitric oxide synthase inhibitor NG-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit.

  1991cited by this paper
• Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle.

  1990cited by this paper
• Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence.

  1989cited by this paper
• Cholinergic neurotransmission in human corpus cavernosum. I. Responses of isolated tissue.

  1988cited by this paper
• Intracavernous injection of papaverine for erectile failure.

  1982cited by this paper
• Iron, the thalassaemias, and malaria.

  1979cited by this paper

• Use of sildenafil citrate in a cat with Eisenmenger’s syndrome and an atrial septal defect

  2015cites this paper
• Effects of chronic treatment with the eNOS stimulator Impaza on penis length and sexual behaviors in rats with a high baseline of sexual activity

  2013cites this paper
• Comparative relaxing effects of sildenafil, vardenafil, and tadalafil in human corpus cavernosum: contribution of endogenous nitric oxide release.

  2009cites this paper
• Oral and non-oral combination therapy for erectile dysfunction.

  2007cites this paper
• Mechanisms of direct relaxant effect of sildenafil, tadalafil and vardenafil on corpus cavernosum.

  2006cites this paper
• Future Options for Combination Therapy in the Management of Erectile Dysfunction in Older Men

  2004cites this paper
• Viability and safety of combination drug therapies for erectile dysfunction.

  2003cites this paper
• Cardioprotection with sildenafil, a selective inhibitor of cyclic 3',5'-monophosphate-specific phosphodiesterase 5.

  2002cites this paper
• Combination therapy for erectile dysfunction: Where we are and what’s in the future

  2002cites this paper
• Efficacy of vardenafil and sildenafil in facilitating penile erection in an animal model.

  2002influential citation
• Nitric oxide regulation of penile erection: biology and therapeutic implications.

  2002cites this paper
• Different distribution of nitric oxide synthase and soluble guanylyl cyclase activities in the detrusor and proximal urethra of the rabbit.

  2002cites this paper
• Synergistic effects of sildenafil on relaxation of rabbit and rat cavernosal smooth muscles when combined with various vasoactive agents

  2001cites this paper